8606 related articles for article (PubMed ID: 16506523)
1. Exosomes as novel therapeutic nanodevices.
Delcayre A; Le Pecq JB
Curr Opin Mol Ther; 2006 Feb; 8(1):31-8. PubMed ID: 16506523
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
Delcayre A; Shu H; Le Pecq JB
Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
[TBL] [Abstract][Full Text] [Related]
3. A systematic approach to exosome-based translational nanomedicine.
Hood JL; Wickline SA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):458-67. PubMed ID: 22648975
[TBL] [Abstract][Full Text] [Related]
4. [Exosomes and anti-tumour immunotherapy].
Chaput N; Andre F; Schartz NE; Flament C; Angevin E; Escudier B; Zitvogel L
Bull Cancer; 2003; 90(8-9):695-8. PubMed ID: 14609758
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
Viaud S; Théry C; Ploix S; Tursz T; Lapierre V; Lantz O; Zitvogel L; Chaput N
Cancer Res; 2010 Feb; 70(4):1281-5. PubMed ID: 20145139
[TBL] [Abstract][Full Text] [Related]
7. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells.
Chen W; Wang J; Shao C; Liu S; Yu Y; Wang Q; Cao X
Eur J Immunol; 2006 Jun; 36(6):1598-607. PubMed ID: 16708399
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
Hao S; Bai O; Yuan J; Qureshi M; Xiang J
Cell Mol Immunol; 2006 Jun; 3(3):205-11. PubMed ID: 16893501
[TBL] [Abstract][Full Text] [Related]
9. Exosomes: a bubble ride for prions?
Février B; Vilette D; Laude H; Raposo G
Traffic; 2005 Jan; 6(1):10-7. PubMed ID: 15569241
[TBL] [Abstract][Full Text] [Related]
10. Exosome-based immunotherapy.
Chaput N; Taïeb J; Schartz NE; André F; Angevin E; Zitvogel L
Cancer Immunol Immunother; 2004 Mar; 53(3):234-9. PubMed ID: 14727085
[TBL] [Abstract][Full Text] [Related]
11. Exosomes: from biogenesis and secretion to biological function.
Keller S; Sanderson MP; Stoeck A; Altevogt P
Immunol Lett; 2006 Nov; 107(2):102-8. PubMed ID: 17067686
[TBL] [Abstract][Full Text] [Related]
12. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization.
Laulagnier K; Motta C; Hamdi S; Roy S; Fauvelle F; Pageaux JF; Kobayashi T; Salles JP; Perret B; Bonnerot C; Record M
Biochem J; 2004 May; 380(Pt 1):161-71. PubMed ID: 14965343
[TBL] [Abstract][Full Text] [Related]
13. Exosome Display technology: applications to the development of new diagnostics and therapeutics.
Delcayre A; Estelles A; Sperinde J; Roulon T; Paz P; Aguilar B; Villanueva J; Khine S; Le Pecq JB
Blood Cells Mol Dis; 2005; 35(2):158-68. PubMed ID: 16087368
[TBL] [Abstract][Full Text] [Related]
14. Direct exosome stimulation of peripheral human T cells detected by ELISPOT.
Admyre C; Johansson SM; Paulie S; Gabrielsson S
Eur J Immunol; 2006 Jul; 36(7):1772-81. PubMed ID: 16761310
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell derived-exosomes: biology and clinical implementations.
Chaput N; Flament C; Viaud S; Taieb J; Roux S; Spatz A; André F; LePecq JB; Boussac M; Garin J; Amigorena S; Théry C; Zitvogel L
J Leukoc Biol; 2006 Sep; 80(3):471-8. PubMed ID: 16809645
[TBL] [Abstract][Full Text] [Related]
16. Exosomes.
Hegmans JP; Gerber PJ; Lambrecht BN
Methods Mol Biol; 2008; 484():97-109. PubMed ID: 18592175
[TBL] [Abstract][Full Text] [Related]
17. Nanovesicular vaccines: exosomes.
Li X; Zhang Z; Beiter T; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2005; 53(4):329-35. PubMed ID: 16088317
[TBL] [Abstract][Full Text] [Related]
18. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
19. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
Clayton A; Mitchell JP; Court J; Mason MD; Tabi Z
Cancer Res; 2007 Aug; 67(15):7458-66. PubMed ID: 17671216
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
